A woman receives a dose of Moderna’s vaccine at the La Gua de Gijn Sports Palace.
The American pharmaceutical company Moderna announced this Friday that it is working on a specific vaccine booster for the Omicron variant, within the framework of a strategy designed to confront this variant detected for the first time in South Africa, which has already been described as “worrying” by the World Health Organization (WHO).
It’s a statement, Modern has pointed out that the newly named Omicron presents a combination of mutations that represents a “Significant potential risk to accelerate the decline in natural and vaccine-induced immunity”.
Against this,
